Robert Azelby - Jun 13, 2024 Form 4 Insider Report for ADC Therapeutics SA (ADCT)

Role
Director
Signature
Lisa Kallebo, as Attorney-in-Fact for Robert Azelby
Stock symbol
ADCT
Transactions as of
Jun 13, 2024
Transactions value $
$0
Form type
4
Date filed
6/14/2024, 05:46 PM
Previous filing
Mar 18, 2024
Next filing
Jun 18, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADCT Common Shares Award $0 +40K +200% $0.00 60K Jun 13, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the annual grant of restricted stock units ("RSUs") made under the Issuer's 2019 Equity Incentive Plan for service as a Director. The RSUs vest one year from the grant date, subject to the Reporting Person's continued service to the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock.